晚期慢性肾脏病中限制蛋白饮食的成本效益
本研究评估慢性肾脏病4-5期患者采用限制蛋白饮食(PRD)的成本,对223例PRD患者和1248例自由饮食对照随访5年。倾向性匹配后62例PRD与123例对照进入分析,PRD组至终末期肾病中位生存48.6个月 vs 对照28.8个月(P=.017),至死亡中位生存107个月 vs 86.6个月(P=.004);观察模型下PRD短期和长期成本均更低。
要点
- 依从饮食处方的PRD患者至ESKD中位生存48.6个月 vs 对照28.8个月(P=.017)。
- PRD组至死亡中位生存107个月 vs 对照86.6个月(P=.004)。
- 观察模型下PRD年成本短期14754 vs 21208欧元(-30%),长期21764 vs 30089欧元(-28%)。
核心结论
- 在依从饮食处方的患者中,限制蛋白饮食延迟透析开始、改善生存并节省费用。
研究设计与样本
- CKD 4-5期患者中,坚持PRD者[0.3 g/kg/天补充极低蛋白饮食(sVLPD);0.6 g/kg/天低蛋白饮食(LPD)]与自由饮食对照随访5年,评估直接和间接成本,并进行理论与观察分析比较估计成本与实际成本。
- 共研究223例PRD受试者和1248例对照(CON);62例坚持饮食的PRD患者和123例倾向性匹配的CON进入分析。
主要发现
- PRD组与CON组至终末期肾病(ESKD)的中位生存分别为48.6个月(95%CI 33.8-72)和28.8个月(95%CI 25-41.7)(P=.017)。
- PRD组与CON组至死亡的中位生存分别为107个月(95%CI 96.2-114.5)和86.6个月(95%CI 66.3-103.8)(P=.004)。
- 理论模型下,PRD vs CON的个体成本在短期随访更高(8255 vs 4595欧元/年,+80%),在长期随访更低(8257 vs 23048欧元/年,-64%)。
- 观察模型(包含ESKD和死亡)下,PRD成本在短期(14754 vs 21208欧元/年,-30%)和长期随访(21764 vs 30089欧元/年,-28%)均更低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The costs of dialysis are not sustainable everywhere, resulting in many avoidable deaths. Interventions that postpone the start of dialysis can save money and lives. This study evaluates the costs associated with protein-restricted diets (PRD) in chronic kidney disease (CKD). METHODS: CKD/4-5 patients adhering to PRD [0.3 g/kg/day, supplemented very-low protein diet (sVLPD); 0.6 g/kg/day, low protein diet (LPD)] and controls on free diet were followed for 5 years, assessing direct and indirect costs. Theoretical and observed analyses compared the estimated and actual costs. RESULTS: A total of 223 subjects under PRD and 1248 controls (CON) were studied; 62 PRD adhering to the diet and 123 propensity-matched CON entered the analyses. In PRD and CON, median survival to end-stage kidney disease (ESKD) was 48.6 [95% confidence interval (CI) 33.8-72] and 28.8 (95% CI 25-41.7) months (P = .017), and median survival to death was 107 (95% CI 96.2-114.5) and 86.6 (95% CI 66.3-103.8) months (P = .004). The monthly costs per patient were 383 euros (€) for CON, 507 € for LPD (+32%) and 767 € for sVLPD (+100%); dialysis monthly costs were 4.150 € (+980%, +720%, +440% vs CON, LPD, sVLPD). By the theoretical model, the individual costs of PRD vs CON were higher in the short follow-up (8255 vs 4595 €/year, +80%), but lower in the long follow-up (8257 vs 23 048 €/year, -64%). At the observed model, which comprises both ESKD and deaths, the costs of PRD were lower either in the short (14 754 vs 21 208 €/year, -30%), or in the long follow-up (21 764 vs 30 089 €/year, -28%). CONCLUSIONS: In patients adherent to diet prescription, PRD delay the start of dialysis, improve survival and save money.
引用
- Bellizzi V, Fordellone M, De Nicola L, et al. Cost-effectiveness of protein restricted diets in advanced CKD. Nephrol Dial Transplant. 2025. PMID: 40815268. doi:10.1093/ndt/gfaf154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。